Founded in 1985, amfAR is dedicated to ending the global AIDS epidemic through innovative research. With the freedom and flexibility to respond quickly to emerging areas of scientific promise, amfAR plays a catalytic role in accelerating the pace of HIV/AIDS research and achieving real breakthroughs. amfAR-funded research has increased ourunderstanding of HIV and has helped lay the groundwork for major advances in the study and treatment of HIV/AIDS. Since 1985, amfAR has invested nearly $290 million in its mission and has awarded grants to more than 2,000 research teams worldwide.

Biotechnology

Clinical Trials

Health Care

amfAR, The Foundation for AIDS Research

Rowena Johnston

John Stanton

Gregorio Millett

Sue Doster

Anthony Ancona

Damion Hänkejh

Kyle Clifford

Raoul Tenazas

James Shackelford, APR

amfAR, The Foundation for AIDS Research

Org chart

Similar companies